These forward-looking statements are not based on historical fact and include statements regarding the anticipated closing of the offering. This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995.
Learn more at Forward Looking Information Our achievements have been widely recognized, including being named a Lux Research Innovator of the Year in 2021. Our nano-optic technology provides anti-counterfeiting security features for government documents and currencies and authentication for brands. Our extensive technology platform enables leading global brands to deliver breakthrough products to their customers in consumer electronics, 5G communications, health and wellness, aerospace, automotive, and clean energy. META® delivers previously unachievable performance, across a range of applications, by inventing, designing, developing, and manufacturing sustainable, highly functional materials. Copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, from Roth Capital Partners, LLC, 888 San Clemente Drive, Newport Beach, California 92660, by telephone at (800) 678-9147, or by email at or from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022, by telephone at (212) 624-2060, or by email at Meta Materials Inc. A final prospectus supplement and the accompanying prospectus relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC's website at.
META MATERIALS REGISTRATION
The offering is being made only by means of a prospectus supplement that forms a part of the registration statement. 333-256632), including a base prospectus, previously filed with and declared effective by the Securities and Exchange Commission (the "SEC") on June 14, 2021. The securities are being offered and sold by the Company pursuant to a prospectus supplement and an accompanying prospectus forming part of a "shelf" registration statement on Form S-3 (Registration No. is acting as financial advisor to the Company for this transaction. Roth Capital Partners and A.G.P./Alliance Global Partners are acting as co-placement agents for the offering. The closing of the offering is expected to occur on or about June 28, 2022, subject to the satisfaction of customary closing conditions. The warrants will become exercisable six months after the issuance date and expire five and a half years after the initial issuance date.
The gross proceeds to the Company from the offering are expected to be approximately $50 million, before deducting placement agent fees and other estimated offering expenses. (the "Company" or "META®") (NASDAQ:MMAT)(FSE:MMAT), a developer of high-performance functional materials and nanocomposites, today announced that it has entered into a securities purchase agreement with certain institutional investors for the purchase and sale in a registered direct offering of 37,037,039 shares of the Company's common stock at a purchase price of $1.35 per share and warrants to purchase 37,037,039 shares at an exercise price of $1.75 per share. HALIFAX, NS / ACCESSWIRE / J/ Meta Materials Inc.
0 kommentar(er)
